New incisionless surgery to treat enlarged prostate
- Date:
- March 31, 2015
- Source:
- University of California, San Diego Health Sciences
- Summary:
- By age 60, more than 50 percent of men in the United States suffer from benign prostatic hyperplasia, a condition that leads to annoying changes in urinary flow. While medical therapy is usually the first line of treatment, a new minimally invasive implant can dramatically reduce symptoms for men.
- Share:
By age 60, more than 50 percent of men in the United States suffer from benign prostatic hyperplasia (BPH), a condition that leads to annoying changes in urinary flow. While medical therapy is usually the first line of treatment, a new minimally invasive implant can dramatically reduce symptoms for men.
"This is a safe procedure for men with BPH to improve urination while preserving sexual function," said Mike Hsieh, MD, urologist at UC San Diego Health System. "This endoscopic procedure is done on an outpatient basis under light sedation with virtually no side effects."
The prostate is a walnut-sized gland that sits below the bladder. When the prostate becomes enlarged, it can restrict or block urine flow causing interrupted or weak urine stream, leakage, urge incontinence and more frequent urination, especially at night.
"More than half of all men in their sixties and as many as 80 percent of men in their seventies and eighties have some symptoms of BPH," said Hsieh. "This is an excellent alternative to traditional surgeries that require removal of prostate tissue, which can cause complications such as erectile and ejaculatory dysfunction."
The implant is comprised of a series of tiny permanent sutures that lift the enlarged prostate open so that it does not interfere with the urethra or bladder anatomy. The implants are delivered through a hollow needle and into the prostate. No urinary catheter is needed post-procedure. Side effects may include burning and blood in the urine during the first 24 hours after the procedure.
The device, called UroLift, was FDA approved in 2013. UC San Diego Health System show-cased this new procedure in a live-surgery during the 8th annual UC San Diego School of Medicine urology postgraduate course.
Hsieh specializes in male fertility and men's health. He treats sexual dysfunction, including low testosterone, erectile dysfunction and Peyronie's disease. He is also a recognized expert in treating male infertility, including ejaculatory disorder, hormone imbalance, sperm production impairment and genetic causes of infertility.
Story Source:
Materials provided by University of California, San Diego Health Sciences. Original written by Jackie Carr. Note: Content may be edited for style and length.
Cite This Page: